














































































































































of MDC and T cells resulting  in parenchymal and vascular regression. Vascular pericytes play  important roles  in  immune
physiology,  and  their  activities  (including  secretion  of  the  Thy‐1  differentiation  protein)  can  be  regulated  by  vascular
autonomic innervation. In tumors, MDC regulate proliferation of neoplastic cells and angiogenesis. Tumor infiltrating T cells
die among malignant cells. Alterations of immune physiology can result in pathology, such as autoimmune, metabolic, and
degenerative diseases, but also  in  infertility and  intrauterine growth  retardation,  fetal morbidity and mortality. Animal
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INTRODUCTION 
 
More than eighty years ago, Alexis Carrel demonstrated 
that leukocyte extracts, like embryonic tissue extracts, 
stimulate multiplication of fibroblasts in vitro, and 
suggested that leukocytes can bring growth-activating 
substances to tissue-specific cells [1]. More recently, 
lymphocytes and also monocyte derived cells (MDC) 
were shown to promote tissue growth and regeneration 
[2-7]. 
 
It has been suggested that only one of the many 
functions of lymphocytes is their participation in host 
immune responses since lymphoid cells as 
“trephocytes” also participate in a number of physiolo-
gical processes aimed at maintaining homeostasis [2]. In 
addition, abundance of tumor-associated macrophages 
is correlated with poor prognosis. It has been hypothe-
sized that besides normal trophic functions, the MDC 
promote tumor progression and metastasis [8]. 
However, while a lot of work has been done to examine 
the influence of various growth factors and cytokines 
produced by lymphocytes and MDC on the cell cycle 
and death in vitro [9-14], little is known about 
interactions between these immune system-related 
mesenchymal cells and tissue-specific cells in vivo.  
 
The biological role of intraepithelial immune system-
related cells has remained an enigma to researchers for 
many years. It is still widely believed that the only role 
of MDC and gamma delta T cells in epithelial tissues 
such as the skin, gut, and lung is in maintaining tissue 
integrity, defending against pathogens, regulating 
inflammation, wound healing, and monitoring 
neighboring cells for signs of damage or disease [5, 6, 
15, 16]. However, there are tissues which do not 
communicate with the outer environment, such as the 
ovarian corpus luteum (CL), in which MDC and T cells 
accompany differentiation and demise of epithelial cells 
[3, 17, 18]. Therefore, we hypothesize that the primary 
role of intraepithelial MDC and T cells is to maintain 
tissue homeostasis, such as proliferation, differentiation, 
and preservation of epithelial or parenchymal cells in a 
functional state (immune physiology). 
 
Alteration of immune physiology can by itself cause 
alteration of tissue function (immune pathology), such 
as rheumatic [19] and degenerative diseases [20]. 
Secondarily, if needed, the MDC and T cells are 
converted into effectors of immunity defending against 
pathogens (immune surveillance). Moreover, the role of 
immune system components in the regulation of tissue 
physiology and pathology should be viewed in context 
with resident mesenchymal cells, such as vascular 
pericytes derived from stromal fibroblasts, as well as 
neuronal signals. 
 
This review article focuses on the role of immune 
system-related cells and molecules they produce in the 
regulation of epithelial and parenchymal cell 
proliferation, differentiation, and aging, and describes a 
theory of the so called Tissue Control System (see below) 
in the reproductive tract, which may be universal for 
other tissues as well. Some implications of immune 
physiology for augmentation of cancer and efficient 
utilization of regenerative medicine are also suggested. 
 
THE TISSUE CONTROL SYSTEM THEORY 
 
To study the role of immune physiology in homeostasis 
of tissues in general, the tissues with fast cellular 
development and demise are essential. The female 
reproductive tract tissues represent one of the most 
dynamic and active structures within the mammalian 
body. Our studies in the late 1970s [21-24] and early 
1980s [25, 26] resulted in the concept of a wider role of 
the immune system (immune system cells and vascular 
pericytes), the so called Tissue Control System (TCS), 
in regulation of ovarian function [27]. The TCS theory 
was further refined when the role of autonomic 
innervation in the regulation of quantitative aspects in 
tissues, including ovarian follicular selection, was 
added, [28, 29] and the TCS theory was revised [30, 
31]. Autonomic innervation plays an important role in 
determination of the extent of tissue development since 
an elimination of limited areas of the cephalic neural 
crest in stage 9 or 10 chick embryos markedly reduced 
the size of the thymus gland or resulted in its absence. 
Small thymic lobes contained both normal thymocytes 
and epithelial cells, but showed delayed development 
[32]. More recently, a role for the immune system-
related cells in the regulation of ovarian aging [33, 34] 
and regulation of asymmetric cell division of germ cell 
progenitors, giving rise to new germ cells during the 
fetal period and adulthood [35-37], have been 
described. 
 
Basic "tissue control unit" and "immune physiology" 
 
The TCS consists of immune system-related cells 
(MDC and T and B lymphocytes), vascular pericytes, 
and autonomic innervation. While immune reactions are 
directed against foreign substances (immune sur-
veillance), the TCS is proposed to regulate regeneration, 
preservation and aging of tissue specific cells ("immune 
physiology") including the female reproductive tissues 
[27, 30, 33]. Ovary, uterus and, in the case of 
pregnancy, the placenta exhibit periodic growth and 
regression, which are extremely rapid and are 
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accompanied by changes in rates of blood flow. 
Therefore, it is not surprising that angiogenesis and 
remodeling of the local epithelium and vascular bed 




















































The basic "tissue control unit" (TCU) is associated with 
tissue microvasculature. Monocyte-derived cells 
(marked M in Figure 1) interact with vascular pericytes 
(P), and both cell types regulate, via growth factors and 
cytokines, proliferation, differentiation, and apoptosis of 
tissue specific epithelial (Ep) and endothelial cells (En). 
The influence of TCU on endothelial cells plays an 
important role in the control of homing of tissue-
committed circulating MDC and T cells, a process 
which is mediated by highly regulated vascular 
adhesion molecules and by chemoattractant factors. The 
intraepithelial MDC [dendritic cell precursors (DCP) 
and dendritic cells (DC)], T cells (T), and natural 
autoantibodies (three types of IgM: IgM1, IgM2 and 
IgM3 - see later, and one type of IgG) [4] play an 
important role in the control of qualitative aspects 
(differentiation and aging) of tissue cells, and 
autonomic innervation controls quantitative aspects of 
tissues by regulation of TCU activity [AI (+ or -)] [3, 4]. 
 
Complete TCS pathway reflects immune system 
phylogeny 
 
Examples of complete TCS involvement in the 
regulation of cellular differentiation, from the stem to 
mature and aged cells, can be found in some stratified 
epithelial tissues, such as uterine ectocervix. The 
stratified epithelium of uterine ectocervix consists of 
four layers of epithelial cells, basal (b), parabasal (pb), 
intermediate (im), and superficial cells (s; see Figure 
2A). The basal layer is formed by a single row of basal 
or stem cells. The parabasal layer contains several 
layers of parabasal (young) epithelial cells, the 
intermediate layer consists of multiple layers of mature 
epithelial cells, and the superficial layer is formed by 
several layers of aged cells. These four morphologically 
distinct layers are divided by three interfaces - b/pb, 
pb/im, and im/s interface. The parabasal and 
intermediate layers can be divided into the lower, mid, 
and upper layers, the superficial layer into the lower and 
upper layers. 
Figure 1. Schematic drawing of  the basic "tissue control unit,"
which  consists  of  monocyte‐derived  cells  (marked  M  in  the
figure),  vascular  pericytes  (P),  and  autonomic  innervation  (AI,
dashed arrow), and the involvement of other components of the
tissue  control  system  (solid  arrows).  Monocyte‐derived  cells
physically  interact with adjacent epithelial  (Ep) and endothelial
cells (En) through the basement membranes (dotted  lines), and
influence  pericytes,  which  secrete  inter‐cellular  vesicles  (ICV).
These  vesicles  collapse  into  the  so‐called  empty  spikes  (ES)
releasing  their  content  (growth  factor/cytokine)  after  reaching
target cells. The activity of pericytes is stimulated or inhibited by
autonomic  innervation  (+  or  ‐)  which  controls  quantitative
aspects of tissues. Interaction of MDC with endothelial cells may
stimulate  homing  of  T  lymphocytes  (T)  and monocyte‐derived
dendritic  cell  precursors  (DCP;  also  known  as  veiled  cells)
differentiating into mature dendritic cells (DC). The dendritic cell
precursors  and  T  cells  interact  themselves  and  stimulate
advanced differrentiation of epithelial cells.  IgMs regulate early
(IgM1),  mid  (IgM2),  and  late  differentiation  (apoptosis)  of
epithelial  cells  (IgM3),  and  IgG  associates with  aged  cells  (see
Figure  2  and  3).  The  monocyte‐derived  cell  system  (including











Mesenchymal cells are present in the lamina propria and 
invade among epithelial cells. Staining for CD14 of 
primitive MDC (Figure 2A) shows small MDC in the 
lamina propria but not within the epithelium. Figure 2B, 
shows association of CD14 cells with the basement 
membrane (arrows) and extension among basal 
epithelial cells (arrowhead). This indicates that 
primitive MDC may stimulate proliferation of stem 
cells. The CD14 is a lipopolysaccharide receptor, and is 
involved in the stimulation of cell proliferation [42]. 
Similar association of CD14 primitive MDC with 
proliferating epithelial cells was detected in ovarian 
cancers (see later). Staining for Ki67 (inset, Figure 2A) 
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shows that this marker of proliferation is expressed in 
the nuclei of parabasal cells adjacent to the b/pb 
interface. This indicates that in the stratified epithelium 
of ectocervix, Ki67 is expressed in postmitotic cells 
leaving the basal layer and beginning differentiation. 
 
These observations indicate that primitive MDC 








































Recognition at the cell surface 
 
Most of the molecules involved in the TCS pathway 
belong to the immunoglobulin (Ig) superfamily of 
molecules. It has been suggested that the involvement 
of Ig-related molecules in tissue interactions is more 
primitive than their involvement in the immune system 
and the immune functions evolved from the sets of 
molecules mediating tissue interactions [43]. One of 
them, the Thy-1 differentiation protein, consists of a 
single Ig domain and represents the most primitive and 
ancestral member of the Ig-superfamily. The Ig-related 
molecules have a diversity of functions, but in most 
cases the common denominator is recognition at the cell 
surface [44]. Also, the only function of Thy-1 
differentiation protein and other Ig-related molecules is 
to mediate recognition, with the consequences of 
recognition being due to the differentiated state of the 
cells. It requires that the correct ligand and receptor are 
expressed on the appropriate cells at the right time [43]. 
 
Staining for Thy-1 differentiation protein (Figure 2C) 
shows pericytes associated with microvasculature 
(arrows) adjacent to the basement membrane. Detail of 
Thy-1 staining (Figure 2D) shows that pericytes secrete 
intercellular vesicles, which migrate among basal 
epithelial cells to the b/pb interface, where they collapse 
into empty structures ("spikes"). Hence, targets for Thy-
1 vesicles appear to be parabasal cells adjacent to the 
b/pb interface, i.e., epithelial cells expressing Ki67 and 
entering differentiation. 
 
These intercellular Thy-1 vesicles have been shown by 
immunoelectron microscopy to exhibit Thy-1 surface 
expression and to contain a substance lacking Thy-1 
staining [30]. They may represent a unique paracrine 
mechanism, so called "targeted delivery," by which 
certain growth factors (vesicle contents) are delivered to 
certain type/stage specific target cells expressing 
receptor for Thy-1 ligand. However, the receptor for 
Thy-1 has not yet been identified. One possibility is that 
the Ki67+ cells entering differentiation are the targets 
for Thy-1+ intercellular vesicles. Also, there is a lack of 
expression of major histocompatibility complex (MHC) 
class I molecules in epithelial cells adjacent to the 
basement membrane, but strong staining in parabasal 
cells (Figure 2E and F). Hence, MHC class I molecules 
could be involved in the recognition of the Thy-1 
ligand. 
Figure  2.  Peroxidase  immunohistochemistry  (brown  color)  of
stratified  epithelium  of  uterine  ectocervix  as  indicated  above
columns  and  in  the  inset.  (A)  CD14  primitive  MDC  in  lamina
propria  (lp) associate with the epithelium basement membrane
(dotted  line). Dashed box  indicates detail shown  in (B). b, basal
layer; pb, parabasal  layer;  im,  intermediate  layer;  s,  superficial
layer.  Arrowheads,  basal/parabasal  interface;  dashed  line,
parabasal/intermediate  interface;  dashed/dotted  line,
intermediate/superficial  interface.  Ki67  staining  (inset)  of
epithelial  cells  in  lower parabasal  layer  (arrowheads).  (B) CD14
MDC (arrows) exhibit extensions among basal cells (arrowhead).
(C)  Pericytes  of  microvasculature  (arrows)  associate  with  the
basement  membrane.  (D)  Detail  from  (C)  shows  intercellular
Thy‐1  vesicles  (arrow)  secreted  by  pericytes  and  migrating
among  basal  cells  (short  black  arrowhead)  to  basal/parabasal
interface  (long  arrowhead).  Yellow  arrowhead  indicates  residual
empty  structures  ("spikes").  (E)  Strong  MHC  class  I  expression
(W6/32 antibody specific for heavy chain) is characteristic of para‐




Targeted delivery of some tissue non-specific 
(stimulating many types of tissues) growth factors to 
particular tissue cells by intercellular Thy-1 vesicles 
could be enabled by tissue specificity of Thy-1 
glycoprotein carbohydrate moieties [45]. 
 
MHC class I and class II molecules are other Ig 
superfamily members. Figure 3A shows that large 
quantities of HLA-DR molecules are secreted by 
precursors of dendritic cells among epithelial cells in 
the mid parabasal layer (arrows). This site-specific 
HLA-DR secretion is particularly evident when DC 
precursors are compared with inactive MDC in the 
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lamina propria (lp) or mature DC in intermediate 
epithelial layers (arrowheads).  
 
These observations indicate that recognition at the cell 
surface by Ig superfamily members may play an 

















































Degeneration of intraepithelial T cells and MDC and 
differentiation of epithelial cells 
 
T cells expressing CD8, which is another member of the 
Ig superfamily, accumulate in the lamina propria, enter 
the epithelium, and migrate through the parabasal layers 
(arrow, Figure 3B), toward the pb/im interface (dashed 
line). T cells entering lower intermediate layers exhibit 
fragmentation (arrowheads). No T cells were detected in 
the mid intermediate layers or at the epithelial surface. 
 
The CD68 epitope of mature intraepithelial MDC, a 
mucin-like molecule belonging to the lysosomal-
associated membrane protein family [46], is expressed 
by MDC in the lamina propria (Figure 3C). However, 
within epithelium, CD68 appears during transformation 
of DC precursors into mature DC, in the upper 
parabasal layers (arrow). Mature DC (black arrowheads) 
secrete CD68 among intermediate epithelial cells, and 
CD68 mucin-like molecules accompany advanced 
differentiation of epithelial cells (white arrowheads) 
including aging in surface layers. 
 
Staining for CD1a, an Ig-related molecule characteristic 
for intraepithelial Langerhans' cells, was not detected in 
the lamina propria (Figure 3D). Dendritic cell 
precursors (arrows) and mature DC (black arrowheads) 
were stained. Mature DC reaching mid intermediate 
layers exhibited fragmentation (white arrowheads) 
similar to that of T cells in the lower intermediate 
layers. 
 
It is apparent that intraepithelial T cells crossing the 
pb/im interface degenerate (Figure 3B), and such 
apoptosis may be required for a release of substances 
enabling maturation of epithelial cells. In addition, 
Figure 2A, 3A, and 3C and D, show that intraepithelial 
MDC also exhibit morphological and immunehisto-
chemical features accompanying their maturation and 
demise. 
Figure 3. Uterine ectocervix immunohistochemistry as indicated
above  columns.  (A) Dendritic  cell  (DC) precursors  secrete HLA‐
DR among parabasal cells (arrows) and differentiate into mature
DC  (arrowheads).  (B)  T  cells  migrate  through  parabasal  layer
(arrow)  to  parabasal/intermediate  interface  (dashed  line)  and
show  fragmentation  after  entering  the  intermediate  layer
(arrowheads).  (C) Transformation of DC precursors  into mature
DC  at  the  top  of  parabasal  layer  is  associated  with  CD68
expression (arrow). Mature DC (black arrowheads) secrete CD68
material  in  intermediate  layer  accompanying  mature
(intermediate)  and  aged  (superficial)  epithelial  cells  (white
arrowheads).  (D) CD1a  is  expressed by DC precursors  (arrows)
and  mature  DC  (black  arrowheads).  Mature  DC  (Langerhans'
cells)  undergo  fragmentation  in  the  mid  intermediate  layer
(white  arrowheads).  (E)  Strong  IgM  binding  (arrowheads)  in
upper  parabasal  (1),  upper  intermediate  (2)  and  upper
superficial layers (3). (F) IgG binds to the entire superficial layer.
For  abbreviations  see  Figure  2.  Reprinted  from  Ref.  [4],  ©
Antonin Bukovsky. 
 
These observations suggest that degeneration of 
intraepithelial T cells and MDC may be required for 
advanced differentiation of epithelial cells.  
 
Association of natural IgMs and IgG with epithelial 
differentiation 
 
Natural autoantibodies are present in the blood of 
normal healthy individuals, and they are almost 
exclusively IgM antibodies, although some IgG and IgA 
natural autoantibodies can also be detected, that bind to 
a variety of self-antigens, including self IgG [47, 48]. 
When compared to IgG, the IgM molecules appear 
earlier in phylogeny and ontogeny [49, 50].  
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Staining of ectocervical epithelium for IgM is shown in 
Figure 3E. Basal and lower parabasal layers are 
unstained, but IgM binding increases toward the pb/im 
interface (#1). In the intermediate layers, a similar 
increase of IgM binding is apparent toward the im/s 
interface (#2). In the superficial layers the most 
prominent staining is evident at the epithelial surface 
(#3). Hence, there is high IgM binding to the upper cells 
in the parabasal, intermediate, and surface layers (white 
arrowheads). IgG does not bind to the basal, parabasal 
or intermediate cells, but shows binding to the entire 
superficial layer (arrowhead, Figure 3F).  
 
These data indicate that natural autoantibodies exhibit a 
stage-specific (differentiation-dependent) binding to 
epithelial cells. Similar stage-specific binding to 
epidermis was also detected for natural IgM and IgG 
autoantibodies in normal human sera [51]. 
 
Interaction of intraepithelial T cells and MDC and T 
cell demise 
 
Basal and parabasal layers of normal ectocervical 
epithelium show the presence of T cells and MDC. A 
possibility exists that, beside interaction with epithelial 
cells, these mesenchymal cell types may interact with 
each other. Figure 4 shows the pb/im interface in detail, 
with staining for HLA-DR MDC (A), CD8 for T cells 
(B) and both (C). T cells appear to assist differentiation 
of DC (white arrowheads) and exhibit an unusual 
elongated shape accompanied by HLA-DR expression 
(white arrows). Above this interface, the mature DC 
(yellow arrowhead) accompany fragmentation of T cells 
(yellow arrows).  
 
These data suggest that transition of parabasal into the 
intermediate epithelial cells at the pb/im interface is 
associated with transformation of DC precursors into 
mature DC with the assistance of activated (HLA-DR+) 
T cells. The T cells entering intermediate layers show a 
loss of HLA-DR expression and undergo fragmentation 
and demise with the assistance of mature DC. 
 
LESSONS FROM MAMMALIAN FEMALE 
REPRODUCTION 
 
Mammalian female reproduction is much more complex 
when compared to males and non-mammalian females. 
Gonads of adult males contain germ cells 
(spermatogonia), which produce fresh gametes. Such 
germ cells are, however, not present in adult female 
gonads of higher vertebrates, including mammals. 
Because of that, a dogma evolved about fifty years ago 
that the process of oogenesis in the animal kingdom 













































DR  peroxidase/CD8  FITC)  viewed  in  dark  field  visible  light  (A), 
incident  fluorescence  (B)  and  dark  field  fluorescence  (C).  (A) 
Interface  (dashed  line)  between  parabasal  and  intermediate 
layers.  White  arrowhead  shows  differentiating  DC,  yellow 
arrowhead  shows mature DC.  Arrow  indicates  activated  T  cell 
with HLA‐DR expression (see below). (B) White arrow indicates T 
cell exhibiting unusual elongated shape at the  interface. Yellow 
arrows  indicate  residual  CD8  expression  in  fragmented  T  cell 
among adjacent im epithelial cells. (C) Activated T cell with HLA‐
DR  expression  (white  arrow)  interacts  with  differentiating  DC 
(white arrowhead). Mature DC (yellow arrowhead) accompany T 





variants. One variant is that the oogenesis appears to 
continue either uninterruptedly or cyclically throughout 
reproductive life - e.g. most teleosts, all amphibians, 
most reptiles and relatively few mammals. The other 
variant is that the oogenesis occurs only in fetal gonads, 
and oogonia neither persist nor divide mitotically during 
sexual maturity - e.g. cyclostomes, elasmobranchs, a 
few teleosts, perhaps some reptiles, all birds, mono-
tremes, and with a few possible exceptions, all eutherian 
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mammals [52, 53]. Nevertheless, in the early 1970s, this 
belief was felt unwarranted due to a lack of detailed 
study of adult mammalian ovaries. A thorough 
reexamination of oogenesis, using modern techniques at 
well-defined stages of the reproductive cycle, was 
suggested [54]. 
 
In addition, it is also currently believed that oogonia in 
fetal ovaries of higher vertebrates originate from 
primordial germ cells, which differentiate into oogonia 
producing definitive oocytes. However, it is apparent 
that germ cells are present at the ovarian surface of 
midpregnancy human fetuses [55]. Our observations 
support the view that primordial germ cells play a role 
in the commitment of the surface ovarian stem cells 
(OSC) toward production of secondary germ cells, and 
then degenerate (reviewed in [56]). Secondary germ 
cells are formed in fetal and adult human ovaries by 
asymmetric division of OSC, with the assistance of 
MDC and T cells [35, 36, 57]. 
 
Mammalian ovarian compartments belong to those 
structures showing most pronounced morphological 
(cellular proliferation, differentiation and regression) 
and functional changes within the body. Regulation of 
ovarian function is quite complex, involving 
interactions between follicular compartments (oocyte, 
granulosa, and theca cells), as well as the influence of 
sex steroids produced by follicles, CL and interstitial 
glands originating from the theca of degenerating 
follicles. Additionally, communication of the ovary with 
the hypothalamo-pituitary system and the influence of 
gonadotropins, autonomic innervation, growth factors 
and cytokines produced by mesenchymal cells derived 
from the immune system, all regulate functions of 
ovarian compartments. While gonadotropins are 
essential for follicular maturation and ovulation [58], 
autonomic innervation is necessary for the regulation of 
follicular selection [59, 60]. 
 
Interactions between the immune system and ovary are 
numerous, as immune cells are associated with 
regulation at every level of the hypothalamo-pituitary-
ovarian axis, regulating growth and regression of both 
follicles and CL [61-63]. 
 
Oogenesis in fetal and adult human ovaries 
 
Earlier observations indicated that secondary germ cells 
develop in fetal ovaries from the somatic OSC, i.e. 
"germinal" (surface) epithelium of the ovary [64]. 
However, until the work of Dustin [65], there were no 
questions regarding the fate of primordial germ cells 
within developing ovaries. He recognized two kinds of 
cells in the germ-line history of amphibians: (1) 
primordial germ cells, which populated the developing 
gonad, differentiated into gonocytes, and degenerated, 
and (2) secondary germ cells originating from the 












































obtained  at  midpregnancy  (24  weeks).  Asymmetric  division
(white arrowheads, panels A and B) of OSC (osc) gives rise to the
OSC  (yellow  asterisks)  and  the  germ  cell  daughters  (red
asterisks).  Symmetric  division  of  germ  cells  follows  (yellow
arrowhead, panel B), which is required for crossing over, and the
secondary  germ  cells  (sgc)  attain  the  ameboid  shape  (dashed
line,  no  hematoxylin  counterstain)  to  leave  the OSC  layer  and
enter cortex. CD14+ primitive MDC interact with the OSC (arrow,
panel  C)  and  accompany  (arrowhead,  panel  D)  symmetric
division of secondary germ cells. CD8 T cells  (panel E) and DR+
cells of  lymphocyte type (panel F) accompany (red arrowheads)
asymmetric  division  of  OSC  (white  arrowheads)  resulting  in






Rubaschkin [66] suggested division of the history of the 
germ cell route (Keimbahn) into three periods. The first 
period begins with the differentiation of primordial 
germ cells, which, however, do not have a perspective 
to become definitive gametes (Urgeschlechtszellen). 
The gonadal development is associated with the 
establishment of the so called germinal epithelium 
(Keimepithel). The second period is associated with the 
appearance of female or male sex specific cells (Ureier 
  
www.impactaging.com              163                                AGING, February 2009, Vol.1 No.2
or Ursamenzellen). The third period deals with the 
development of the sex-specific glands. 
 
The germ cell route of Rubaschkin again raised a 
question of the fate of primordial germ cells [67]. 
Winiwarter and Sainmont [68] suggested that these cells 
degenerate after reaching the sex gland, and that 
definitive germ cells arise from the ovarian "germinal" 
epithelium. 
 
Our observations indicate that secondary germ cell 
development in midpregnant human fetal ovary is 
triggered by MDC and T cells (Figure 5). The germ 
cells are depleted of major histocompatibility complex 
class I (MHC-I) expression (red asterisks, Figure 5A 
and B), and they originate by asymmetric division 
(white arrowheads) from OSC densely expressing 
MHC-I (yellow asterisks). A symmetric division of the 
germ cells, required for crossing over of chromosomes 
[69], follows (yellow arrowhead, panel B). The germ 
cells (gc) take on an ameboid shape (dashed line, no 
hematoxylin counterstain), and enter the adjacent 
ovarian cortex. Primitive CD14-expressing MDC 
interact with OSC (arrowhead, panel C), and 
accompany (arrowhead, panel D) subsequent symmetric 
division of the germ cells (asterisks). T cells expressing 
CD8 (panel E) and showing activation (HLA-DR 
expression, panel F) accompany (black arrowheads) 
asymmetric division of OSC (white arrowheads, panels 
E and F). Note that during asymmetric division the 
emerging germ cells daughters (red asterisks) are 
substantially larger than OSC daughter cells (yellow 
asterisks). The activated (HLA-DR+) MDC are 
associated with growing (gf and arrowheads, panel G) 
but not resting primordial follicles (pf) [36, 70]. 
 
Similar emergence of secondary germ cells by 
asymmetric division of OSC triggered by MDC and T 
cells has been observed in adult human ovaries [35, 57] 
and expression of a meiosis marker, the meiotic entry 
synaptonemal complex protein-3 (SCP3), in segments 
of tunica albuginea and OSC, and in some oocytes of 
primordial follicles was detected in functional adult 
human and monkey ovaries [71]. In addition, we also 
have shown emergence of secondary germ cells by 
asymmetric division of OSC triggered by MDC and T 
cells in adult rat ovaries [72]. This indicates that MDC 
and T cells induce emergence of secondary germ cells 
from the OSC in various mammalian species. 
 
Adult human ovaries exhibiting neo-oogenesis showed 
association of CD14 primitive MDC with OSC (arrows, 
Figure 6A). During asymmetric division, both the 
emerging germ cell daughter (red asterisk) and the OSC  
daughter cells (yellow asterisk) were accompanied by 
extensions of CD14 MDC (see color matching 
arrowheads). It is apparent, however, that interaction of 
CD8 T cells is unique for the emerging germ cells (red 
arrowheads, Figure 6B), see also Figure 5E and F. This 
suggests that the number of interacting CD8 T cells may 
determine the number of emerging secondary germ cells 
in fetal and adult human ovaries. As in fetal ovaries, 
asymmetric division resulted in the emerging germ cell 
daughter being larger than the OSC daughter. The 
HLA-DR (activated) MDC accompanied (arrowhead, 
Figure 6C) migration of germ cells exhibiting ameboid 
shape through the dense upper ovarian cortex toward 
ovarian vessels, which they entered [57]. 
 
Dual color immunohistochemistry has shown that 
during asymmetric division OSC daughters retain 
cytokeratin expression (blue color, Figure 6D), but the 
emerging secondary germ cell loses it and attains 
expression of meiotically expressed PS1 carbohydrate 
(brown color) [73, 74]. As in fetal ovaries, symmetric 
division of secondary germ cells follows (Figure 6E). 
The secondary germ cells entering ovarian venules 
enlarge to the size of small oocytes and are caught in 
the deep ovarian cortex by the arms (a, Figure 6F) of 
primitive granulosa cell nests (n) lining the venule 
lumen (vl). More advanced nest-oocyte assembly 
resembling an occupied bird's nest is shown in Figure 
6G. See [35] for more data. 
 
These observations indicate that secondary germ cells 
develop from OSC in adult human ovaries and form 
new primordial follicles by assembly with granulosa 
cell nests. 
 
Expression of meiotic entry SCP3 protein in adult 
human and monkey ovaries 
 
In a recent study, Liu and colleagues compared 
expression of meiotic marker SCP3 in fetal and func-
tionally undefined adult human ovaries [75]. The authors 
argued that SCP3 protein was not detectable in the tunica 
albuginea, OSC or in oocytes of primordial follicles in 
adult ovaries, and hence concluded that no meiotic 
oocytes are present in ovaries during adulthood. In a 
subsequent commentary, Tilly and Johnson [76] indica-
ted that the lack of evidence on neo-oogenesis in adult 
human females is not evidence of its absence, and on the 
contrary that some data of Liu et al. [75] support the 
existence of neo-oogenesis in adult women. Subsequently 
we reported that using the same SCP3 antibody, immune-
reactivity with segments of tunica albuginea and OSC, 
and in some oocytes of primordial follicles in functional 
adult human and monkey ovaries was detected [71]. 
 
  

















































Meiotic entry SCP3 protein is expressed in precursor 
cells of OSC in some segments of tunica albuginea in 
functional adult human ovaries (arrowhead, Figure 6H) 
and also in OSC cells of human (panel I) and monkey 
ovaries [71]. Moreover, SCP3 immunostaining was 
observed  in the nucleoli of oocytes in some primordial 
















































oogenesis  in  adult  rat  ovaries  (N‐P).  (A)  During  asymmetric  division  (white  arrowhead),  the  CD14 MDC  interact with  both  the OSC
daughter (yellow arrowhead) and germ cell daughter (red arrowhead). (B) T lymphocytes, however, interact with the germ cell daughter
only  (red  arrowheads).  (C)  Ameboid  germ  cells  (dotted  line) migrating  through  the  dense  ovarian  cortex  (oc)  are  accompanied  by
activated MDC (arrowhead). (D) Asymmetrically dividing OSC produce a new PS1+ germ cell (red asterisk) and CK+ progenitor cell (yellow
asterisk). (E) In the tunica albuginea (ta) germ cells (asterisks) symmetrically divide (arrowhead). (F) Capture of oocyte (o) from the blood
circulation  by  an  arm  (a)  of  granulosa  cell  nest  (n)  lining  the  venule  lumen  (vl);  e,  endothelial  cells.  (G) Oocyte  nest  assembly.  (H)
Segments of tunica albuginea (ta) in ovaries with follicular renewal (early luteal phase) showed strong SCP3 expression of mesenchymal
(arrowheads) OSC precursors under ovarian surface (os). (I) Staining of OSC (osc and arrowhead) was apparent in other segments ‐ note
lack  of  staining  of  tunica  albuginea  under  developed  OSC.  (J)  Postovulatory  human  ovaries  showed  staining  of  oocyte  nucleoli
(arrowhead)  in  some  primordial  follicles.  (K)  In monkey  ovaries,  similar  staining  of  oocyte  nucleoli  in  some  primordial  follicles was
observed  (red  vs. white arrowhead).  (L)  Staining of paired  chromosomes oocyte was observed  in human ovaries  (inset  shows higher
magnification). (M) Adult rat testis (positive control) showed staining of condensed chromosomes in spermatogonia (red arrowhead) and
progression of meiotic division  in primary  spermatocytes  (black arrowhead). Oogenesis  in adult  rat ovaries  is  initiated by asymmetric
division of OSC (white arrowhead, N) showing unstained OSC daughter (yellow asterisk) and ZP+ (magenta color) germ cell daughter (red
asterisk)  accompanied  like  in  human  ovaries  by  a  lymphocyte  (black  asterisk  and  brown  color).  Symmetric  division  of  ZP+  oogonia
(asterisks, O)  follows,  and  is  accompanied  (P)  by MDC  (yellow  arrowhead).  Blue  arrowheads  in  (P)  indicate  association  of  primitive
granulosa cells with this process. ZP, zona pellucida; LCA, leukocyte common antigen; W6/25, marker of rat MDC. Details in text. Adapted




key ovaries (red vs. white arrowhead, panel K). Earlier, 
Tres had reported that male germ cells exhibit nucleolar 
SCP3 expression during early stages of meiotic 
prophase [77]. In addition, an SCP3+ synapsis of two 
chromosomes was detected in human primordial follicle 
oocytes (arrowhead, panel L and insert), possibly 
representing XX chromosomal synapsis, as sex chromo-
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somes start synapsis during early zygotene, before 
autosomes synapse [77]. Rare SCP3+ oocytes (less than 
10%) were detected in midfollicular phase ovaries. The 
highest expression of SCP3 (10 to 30% of primordial 
follicle oocytes) was found in postovulatory ovaries 
during the early luteal phase in younger (up to 38 years 
of age) women. However, at age 42, postovulatory 
ovaries showed no SCP3 expression. Virtually no 
staining of oocytes was observed in three younger 
women studied during the mid- and late luteal phases, 
or in polycystic ovaries [71]. Panel M shows SCP3 
expression in adult rat testes (positive control). Note 
SCP3 immunostaining of condensed chromosomes in 
spermatogonia (red arrowhead) and advanced 
progression of meiotic division in primary 
spermatocytes (black arrowhead) in a 2-month-old rat 
male gonad.  
 
These observations indicate that SCP3 is expressed in 
adult human and monkey ovaries, confirming that neo-
oogenesis occurs in primates during adulthood. 
Preparation for meiotic activity may have already 
occurred at the level of tunica albuginea stem cells, and 
meiotic prophase activity may continue and terminate in 
oocytes of newly formed follicles. As indicated by 
Kayisli and Seli: “If proven to occur in human, the 
implications of de-novo oocyte formation from stem 
cells would be significant for our understanding of 
fertility and our approach to its preservation" [78]. 
 
Adult rat ovaries 
 
Studies of human ovaries raise the question as to 
whether formation of new oocytes exists in other adult 
mammalian species. We studied ovaries of adult rat 
females by immunohistochemistry and found migrating 
ameboid germ cells [36] resembling the migrating germ 
cells found in adult human ovaries [35], and clusters of 
dividing germ cells expressing zona pellucida (ZP) 
proteins in unstained solid epithelial cords. These 
observations indicated that germ cells, some of which 
exhibit the ameboid shape, may develop in adult rat 
ovaries. These cells may originate from the OSC. An 
alternative site is the ovarian hilar region, which 
contains sex cords replete with bone morphogenetic 
protein (BMP) ligands and receptors [79]. 
 
Using a double staining immunohistochemistry 
technique [72], we found that bone marrow derived 
cells (MDC and T cells) are also involved in triggering 
germ cell development from the OSC in adult rats. The 
MDC (not shown) and T cells (black asterisk, Figure 
6N) accompanied asymmetric division of OSC giving 
rise to ZP+ germ cells  (red vs.  yellow asterisk). These 
descend into the adjacent solid epithelial cord, also 
described in ovaries of adult guinea pigs [80], a source 
of granulosa cells under the OSC layer. Large oogonia 
divided symmetrically (crossing over) in the solid 
epithelial cords (Figure 6O; see also [81] for mice), and 
such division was accompanied by MDC (yellow 
arrowhead, panel P). Blue arrowheads indicate 
association of solid epithelial cord cells representing 
primitive granulosa cells. Note that in adult human 
ovaries symmetric division of emerging germ cells is 
apparent (Figure 6E) and no dividing oogonia were 
detected [35], while in adult rat ovaries besides 
emerging germ cells [36], the new oogonia can also 
symmetrically divide (panels O and P).  
 
Divided rat oogonia separated, and the resulting oocytes 
formed new primordial follicles. Monocyte-derived 
cells also accompanied the growth of primordial 
follicles. In adult rats lacking OSC after neonatal 
estrogen treatment, the germ cells indeed originated in 
the ovarian hilar region (see above) and formed 
primordial follicles in the juxtaposed (deep) ovarian 
cortex [72]. 
 
These observations indicate that similar pathways of 
new oocyte development exist in different mammalian 
species, although there may be variations in the routes 
of granulosa cells contributing to the formation of new 
follicles. For example, the availability of epithelial cell 
cords in adult rats resembles human fetal ovaries [36]. 
In contrast, OSC in adult human ovaries produce the 
cord cells which are very similar to some of the 
granulosa cells. In some areas of the ovary, cords 
fragment and appear as small 'nests' of epithelial cells. 
Typically, these epithelial nests (fragmented cords) lie 
in proximity to primordial follicles [82, 83]. 
 
Our observations indicate that these primitive granulosa 
cell nests are descending into the deep cortex where 
they assemble with vessels to catch circulating oocytes 
or surround OSC crypts to assemble with migrating 
germ cells [35]. Hence in adult women, the number of 
granulosa cell nests determines the number of newly 
formed follicles, since superfluous new oocytes 
degenerate in medullary vessels. Accordingly, even if 
some new oocytes form after the end of the prime 
reproductive period (PRP; women between menarche 
and 38+2 years of age - reviewed in [35, 84]), the lack 
of developing granulosa cell nests precludes the 
formation of new follicles. Due to the progressive 
diminution of the remaining aging follicular pool, 
menopause occurs. Preliminary termination of either 
new oocyte or granulosa cell nest formation results in 
premature ovarian failure [85]. 
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Bone marrow derived cells and the "storage" vs. a 
"prime reproductive period" doctrines 
 
In 1923, Edgar Allen [81] introduced a distinction 
between the "storage” theory, which is based on the 
opinion that there may never be any increase in the 
number of oocytes beyond those differentiating during 
fetal or perinatal ovarian development [86], versus the 
"continued formation” of oocytes theory, which 
suggests that oogenesis is maintained throughout the 
life of mammals [35, 57, 71, 80, 81, 87]. 
 
The currently prevailing "storage" doctrine, as 
elaborated by Sir Solly Zuckerman and collaborators 
(reviewed in [88]), is based on the following milestones 
(assumptions):  
A) Total number of oocytes declines with age by a 
simple regression. 
B) Oocytes persist in rat ovaries lacking ovarian surface 
epithelium (i.e. OSC). 
C) Oogonia do not persist in adult ovaries. 
D) Oogenesis from somatic stem cells is missing. 
E) Mitotic division of oogonia is missing.  
 
Regarding assumption (A), there is no significant 
decline during 20 years of reproductive life, between 
18-38 years of age in humans [89]. In addition, Faddy 
[90] indicated that the pattern of primordial follicle 
number decline is not exponential, but more bi-
exponential corresponding to a 'broken-stick' regression 
of logged total numbers of follicles against age. Such a 
model implies an abrupt change in the exponential rate 
of follicle loss at age 38 years, and is thus rather 
implausible biologically [90]. The model, however, will 
be biologically plausible when follicular renewal is 
considered to act before (slow decay rate during oocyte 
renewal) but not after 38 years of age (fast decay rate 
during oocyte storage). 
 
Regarding the argument (B) that OSC are not essential 
for neo-oogenesis since the oocytes persist in ovaries 
lacking OSC, we recently demonstrated that in rat 
ovaries lacking OSC, the oocytes originate by an 
alternate pathway, from medullary somatic stem cells; 
primordial follicles are formed in the juxtaposed (deep) 
ovarian cortex [72]. 
 
Assumption (C) is in principle correct, since the 
oogonia should not persist in adult ovaries, due to the 
threat of accumulation of genetic anomalies with age. 
Yet, in adult human females, precursors of germ cells 
are tunica albuginea stem cells [35], which have a 
mesenchymal character and are certainly more resistant 
to environmental threats and to the accumulation of 
genetic abnormalities with age. Differentiation of OSC 
from ovarian tunica albuginea precursors is triggered by 
activated MDC [70]. 
 
Regarding point (D), step by step oogenesis and 
follicular renewal from somatic stem cells have been 
described in fetal and adult human and adult rat ovaries 
[35, 36, 57, 72]. 
 
Finally, regarding query (E), the mitotic division of 
newly formed germ cells and oogonia has been 
described in human and rat ovaries [35, 72]. 
 
Regarding both the storage and continued oocyte 
formation paradigms, there appears to now be a 
consensus that germ cells per se do not persist in adult 
mammalian ovaries from the fetal/perinatal period. 
From the view of groups attempting to re-establish the 
"continued formation" doctrine and search for the origin 
of new germ cells in adult humans and laboratory 
rodents [35, 57, 72, 91], there appears to be a consensus 
that during adulthood the germ cells originate from 
progenitor cells. Two possible mechanisms for the 
generation of new oocytes in postnatal mammals have 
been recently proposed by Joshua Johnson [92]. 
 
1) New oocytes are produced via germ stem cells that 
reside in an extragonadal location, the bone marrow, 
and are released into the peripheral blood. These 
progenitors migrate to the ovary, where they may 
engraft as new oocytes within new follicles [91]. The 
developmental potential of labeled oocytes after bone 
marrow transplantation remains unclear [93]. 
 
 2) New oocytes are produced by a transformative 
mechanism. Ovarian bipotential progenitor cells 
produce both new oocytes and somatic (granulosa) cells 
within the ovary [35, 57, 94]. 
 
More recently, it has been reported that bone marrow 
transplantation improves attenuated fertility after low 
dose chemotherapy in mice, although all newborns were 
of recipient and not of bone marrow donor origin [95]. 
Tilly's group introduced in 2004 the idea of the origin of 
female germ cells in mice from persisting germline stem 
cells in the ovary [96]. A year later, this was replaced 
with the idea of the extra ovarian origin of mouse 
putative germ cells from bone marrow [91]. They also 
now found the idea on the origin of germ cells from 
bone marrow untenable, suggesting that bone marrow 
cells function primarily by reactivating host oogenesis 
impaired by chemotherapy [95]. However, they did not 
indicate which bone marrow cells are involved and how 
and where the new germ cells originate in the recipient. 
Our studies suggested that the bone marrow derived 
white blood cells (monocytes and T lymphocytes) 
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accompany the origin of new germ cells from OSC in 
fetal and adult human and adult rat ovaries, or from 
medullary stem cells in adult rats lacking OSC 
(reviewed in [72, 84]). Furthermore, activated resident 
vascular pericytes and bone marrow derived monocytes 
accompany initiation of follicular growth, selection, and 
preovulatory maturation of autologous oocytes [57, 70, 
84]. We propose that the lack of activated pericytes and 
bone marrow derived monocytes committed for the 
stimulation of follicular growth and maturation of the 
allogeneic (donor) oocytes may be why the primordial 
follicles formed from circulating donor germ cells were 
found to be unable to differentiate and undergo 
ovulation [91, 93, 95]. 
 
During certain periods of life, however, the storage of 
oocytes in mammals may occur. Recently, we attempted 
to establish a harmony between the "storage" and 
"continued formation" theories by proposing the "prime 
reproductive period" theory [56, 72, 84, 97] as follows: 
the “storage” theory pertains to two periods of the life in 
human females, that is between the termination of fetal 
oogenesis and puberty or premenarcheal period (about 
10 to 12 years), and premenopausal period following 
the end of the PRP until menopause (also about 10 to 12 
years). On the other hand, the “continued formation” 
theory accounts for the follicular renewal during the 
PRP (about 25 years, i.e., between menarche and 38+2 
years of age), and ensures an availability of fresh 
oocytes for the development of healthy progeny. Since 
the number of primordial follicles begins to diminish in 
aging rodents [98], one may consider the relevance of 
the PRP theory in these species as well. 
 
In conclusion, we are convinced that the neo-oogenesis 
and follicular renewal during the PRP exists throughout 
the animal kingdom, including higher vertebrates. 
 
Vascular pericytes and MDC regulate differentiation 
and selection of human ovarian follicles 
 
Within the adult human ovary, cohorts of primordial 
follicles occupy distinct areas in the cortex (dashed line, 
Figure 7A), characterized by diminution of Thy-1 
expression in stromal cells [35, 70] In these areas 
stromal cells show enhanced MHC class I expression 
[57]. Most of the primordial follicles remain in the 
resting state (rf, Figure 7A), but some show an increase 
in size and apparent transformation into growing 
(secondary) follicles (gf) accompanied by increased 
activity (Thy-1 release) of pericytes (arrowheads, 
Figure 7B). This could be stimulated by due permissive 
signals from innervation of follicular vessels 
(autonomic innervation +, Figure 1), since innervation 
controls quantity, but not quality of tissues and their 
structures [32]. Initiation of follicular growth is also 
associated with an interaction of pericytes (arrowheads, 
Figure 7B) and activated macrophages (semi-parallel 
section, Figure 7C). Note HLA-DR+ material, an 
indicator of activated MDC [99], secreted near 
granulosa cells and oocyte (arrowhead, Figure 7C), and 
accumulating in the nuclear envelope of granulosa cells 
(black vs. white arrows). Figure 7D (semiparallel 
section to B and C) shows strong MHC class I expres-
sion, an indicator of epithelial cell differentiation (see 
Figure 2F), and the cuboidal shape of granulosa cells, 











































Figure  7.  Selection  of  secondary  (A‐D)  and  preovulatory 
(dominant)  follicles  (E‐F)  in  the adult human ovary. Staining  for 
Thy‐1, HLA‐DR (DR), MHC class I light chain (β2m), cytokeratin 18 
(CK)   and CD68 of mature MDC, as  indicated  in panels. Dashed 
line  in  (A)  indicates  an  area  exhibiting  diminution  of  Thy‐1 
expression by  stromal cells.  (B), detail  from  (A). C) and  (D) are 
semi‐parallel  sections  to  (B).  Dashed  line  in  (E‐J),  follicular 
basement membrane. rf, resting  follicles; gf, growing  follicle; p, 
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Usually only one dominant follicle is selected for 
ovulation during the mid follicular phase of each 
menstrual cycle in the human ovary. This process of 
follicular selection still remains an unresolved puzzle. 
Premature stimulation with gonadotropins results in 
multiple ovulations, suggesting that more than one large 
antral follicle in the cohort developing up to the middle 
of the follicular phase is capable of ovulating. Hence, 
under normal conditions, there seems to be a 
competition among growing follicles themselves in an 
attempt to reach the mature state and suppress the 
development of others. In contrast with this traditional 
view, our data indicate that the follicles showing the 
most advanced development during selection are not the 
dominant follicles. A critical role in the process of 
dominant follicle selection appears to belong to the 
theca interna compartment [29, 100]. 
 
In antral follicles of mammalian ovaries, including 
humans, two clear cut zones in theca interna were 
detected. About one-third of the cells corresponding to a 
more internal region (inner or vascular layer) were not 
stained with luteinizing hormone receptor, 3-beta-
hydroxysteroid dehydrogenase, and P450-17alpha-
hydroxylase antibodies. This contrasted with the 
remaining two-thirds of cells corresponding to the 
external regions (outer or steroidogenic layer), which 
were strongly labeled [101-103]. In dominant follicles, 
the inner vascular layer of theca interna contains 
vascular pericytes secreting Thy-1 differentiation 
protein among differentiating granulosa cells [27, 29]. 
 
Figure 7E shows cytokeratin staining of a human 
dominant follicle in mid-follicular phase with multiple 
granulosa cell layers (g) adjacent to the basement 
membrane (dashed line). Under the follicular membrane 
is a vascular theca interna layer (vl) surrounded by a 
steroidogenic theca interna layer (t) with narrow vessels 
(v). Staining for Thy-1 (Figure 7G) shows that a high 
activity of Thy-1 pericytes is restricted to the vascular 
layer. The MDC releasing CD68 (Figure 7I) are absent 
from the steroidogenic layer (arrows), but abundant in 
the vascular layer. 
 
Large antral follicles undergoing atresia in the same 
ovary show detachment of granulosa cells from the 
basement membrane (Figure 7F). This is accompanied 
by activation of pericytes in the steroidogenic layer 
(white t, Figure 7H) and dilatation of vascular lumina 
(v; compare panels F and H vs. E and G). In addition, 
the MDC in the steroidogenic layer become highly 
activated (white arrowhead, Figure 7J), but those in the 
vascular layer show low or no CD68 release (arrow). 
Instead, the MDC from the vascular layer invade among 
granulosa cells (black arrowhead) [70]. 
Since regulation of follicular selection involves 
autonomic innervation [59, 60], we suggest that 
activation of pericytes in the steroidogenic thecal layer 
of follicles undergoing atresia is caused by permissive 
neuronal signals. On the other hand, retardation of 
pericyte activity in a dominant follicle steroidogenic 
thecal layer during selection is caused by a lack of such 
signals (autonomic innervation -, Figure 1). 
 
Novel aspects of follicular selection 
 
Follicles are selected twice during their development 
(secondary from primordial and preovulatory from 
antral follicles), but the consequences for the remaining 
follicles are different. First, during basal growth, 
secondary follicles are selected from primordial follicles 
under the control of growth factors of paracrine origin. 
Unselected primordial follicles remain in the resting 
state. The selection of secondary follicles is associated 
with activation of pericytes in adjacent micro-
vasculature, possibly due to permissive signals from 
autonomic innervation, which is involved in the 
regulation of quantitative aspects (amounts) of specific 
cells and structures in tissues from early periods of life 
[32, 104]. This also causes an activation of perivascular 
MDC. Hence, during growth initiation, the selected 
follicles are stimulated in further development. 
 
After attaining the antral stage, follicles become 
gonadotropin dependent and immature granulosa cells 
can be affected by thecal androgens [105]. Hence, 
premature acceleration of theca interna steroidogenic 
layer development may cause follicular atresia by thecal 
androgens via alteration of immature granulosa cells 
lacking aromatase. This is associated with conversion of 
follicular MDC into phagocytes infiltrating the 
follicular antrum. We show that during selection of pre-
ovulatory follicle, the pericytes in steroidogenic layer of 
theca interna in non-dominant follicles are highly 
activated and accompanied by activated MDC. In 
contrast, non-activated MDC are present in the vascular 
layer adjacent to the follicular basement membrane, and 
invade the granulosa layer of non-dominant follicles. 
Hence, it appears that the dominant follicle is selected 
by a process of temporary retardation of steroidogenic 
thecal differentiation, possibly by a negative influence 
of autonomic innervation on thecal pericytes. Extracts 
of the superior ovarian nerve have been shown to inhibit 
thecal cell androstenedione production [106, 107]. 
 
Once the dominant follicle matures into the 
preovulatory stage, with the ability of mature granulosa 
cells to convert androgens into estrogens [105], 
pericytes and MDC in both steroidogenic and vascular 
layers of the dominant follicle show high activity [29, 
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57]. Taken together, acceleration of steroidogenic thecal 
layer development during follicular selection results in 
premature androgen production causing detachment of 
immature granulosa cells from the follicular basement 
membrane, invasion of macrophages into the follicular 





The CL of the menstrual cycle has the shortest lifespan 
of any tissue structure in the mammalian body. In 
women, its function ceases after two weeks, followed 
by transformation into the amorphous corpus albicans. 
The association of various types of immune cells with 
the CL during its development and regression indicates 
that the immune system is involved in CL management. 
The absence of the CL during early ontogeny, including 
immune adaptation, suggest that the CL could be 
viewed by the immune system as a graft [17]. Although 
the ovary is densely innervated, with autonomic nerves 
associated with thecal vessels of all follicles regardless 
of the stage of development, the luteal vessels lack 
autonomic innervation [108]. Another feature of the CL 
is that, in contrast to some other tissues, such as the 
liver, it is unable to regenerate. Moreover, during 
pregnancy, the CL can survive and function for an 
extended period. This longevity is associated with a 
change in behavior of luteal mesenchymal and immune 
cells. Thus the CL is a unique model for the study of 
TCS mediated mesenchymal-epithelial interactions 
without influence of innervation. 
 
Figure 8A shows a young CL (2 days after the LH peak) 
with high activity of Thy-1 pericytes, characterized by 
secretion of intercellular vesicles (arrow) which are 
converted into empty "spikes" (arrowhead). A mature 
CL (5 days post ovulation) shows partial diminution of 
pericyte activity (Figure 8B). In the CL of pregnancy 
(3rd month) the pericytes persist in an inactive state 
(Figure 8C). Regressing CL (early follicular phase of 
the next cycle) shows regression of pericytes (Figure 
8D) and infiltration by T cells (inset). This is 
accompanied by IgG binding to luteal cells (not shown). 
Similar features were observed during CL regression at 
the end of pregnancy. In the corpus albicans no luteal 
cells are present and remnants of pericytes accompany 
regressing microvasculature (Figure 8E).  
 
The IgM distribution is shown in Figure 8F to J. When 
compared to IgG, IgM is expressed phylogenetically 
(sharks) and ontogenetically (immature B cells) much 
earlier [99]. Accordingly, IgM shows binding to tissue 
cells at various stages of their differentiation. In the 
stratified epithelium IgM binds to the young (parabasal) 
cells (IgM1), isolated mature and all aging (top of 
interstitial layer) cells (IgM2), and a layer of the most 
superficial cells (IgM3) [3, 51] - see also above. The 
IgM also binds to endothelial cells, depending on the 








































panels,  in  human  corpora  lutea  and  ovarian  adenocarcinomas 
(OvCa).  YCL,  young CL; MCL, mature CL; CLP, CL of pregnancy; 






Figure 8F shows strong IgM binding to the granulosa 
lutein cells in the young CL. Note a lack of binding to 
the endothelium of microvasculature (mv). In the 
mature CL no IgM binding is apparent to either 
granulosa lutein or endothelial cells (Figure 8G). The 
CL of pregnancy shows no IgM binding to granulosa 
lutein cells, but strong binding to the vascular 
endothelial cells extended toward the pericytes (Figure 
8H). In regressing CL (Figure 8I), IgM binds to both 
regressing luteal cells and vascular components. In the 
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corpus albicans, IgM binds to the amorphous structure 
and to residual microvasculature (Figure 8J). 
 
Perivascular primitive CD14 MDC show high activity 
(secretion of CD14 material into the intercellular space) 
in the young CL (Figure 8K). This is accompanied by 
secretion of CD68 and HLA-DR by MDC. The activity 
of MDC diminishes in the mature and aging CL, where 
the MDC show a conversion into dendritic cells. 
Subsequently, from the beginning of the next menstrual 
cycle, the luteal cells show strong expression of various 
MDC and leukocyte markers, including CD14, CD68, 
HLA-DR, leukocyte-common antigen, and CD4 of 
MDC and of helper T cells [17].  
 
These observations indicate that the TCS components 
vary with CL development, preservation during 
pregnancy, and regression. High activity of vascular 
pericytes and primitive MDC is characteristic for the 
CL development, and T cells and dendritic cells 




Ovarian cancers represent a wide variety of cell types 
with variable metastatic potential. The most common 
types are adenocarcinomas, often expanding into the 
peritoneal cavity and metastasizing to the omentum. 
Depending on the location (primary vs. metastatic), and 
stage of differentiation (poor, moderate, well 
differentiated), the activity of stromal and intraepithelial 
mesenchymal cells in ovarian carcinomas varies. Figure 
8L-O, shows several examples of mesenchymal cell 
activity in various ovarian adenocarcinomas in addition 
to those reported earlier [108, 109]. 
 
Figure 8L shows high activity of Thy-1 pericytes in a 
poorly differentiated ovarian adenocarcinoma. Note 
secretion of Thy-1 vesicles (arrow), the presence of 
empty spikes among malignant cells (black arrowhead) 
and in the sprout of endothelial cells (white arrowhead). 
Such activity is similar to that seen in the young CL 
(see Figure 8A). However, pericytes in well 
differentiated adenocarcinomas show low or no activity, 
similar to that observed in the persisting CL of 
pregnancy. 
 
IgM binding is restricted to the microvasculature 
(Figure 8M), and none of the 20 adenocarcinomas 
investigated showed IgM binding to proliferating 
(Ki67+) or differentiating malignant cells. This situation 
is also similar to the persisting CL of pregnancy. 
 
The most common feature seen in ovarian cancers was 
the high activity of MDC. Figure 8N shows secretion of 
CD14 from immature MDC into the malignant 
epithelium (see also young CL in Figure 8K). Similar 
activity was observed in CD68 and HLA-DR monocyte-
derived cells [109]. A proportion of adenocarcinomas 
(9/20) showed infiltration of malignant cells by T 
lymphocytes. Panel O shows normal T cells within the 
malignant stroma (black arrow). T cells which enter 
differentiating malignant epithelium release CD8 
material among malignant cells (white arrow). Deeper 
within the tumor, the T cells become smaller and exhibit 
low CD8 expression (arrowheads in inset), features 
characteristic of their apoptotic fragmentation [4, 108]. 
 
MDC in ovarian epithelial inclusion cysts and pro-
inflammatory cytokines in ovarian cancers 
 
Epithelial inclusion cysts (EICs), are formed by 
trapping of ovarian surface epithelium (OSE) cells 
within the ovarian stroma during ovulation wound 
repair or ovarian surface inflammatory processes. It is 
widely accepted that EICs constitute a preferential site 
of ovarian carcinogenesis. OSE cells in EICs undergo 
Müllerian metaplasia and acquire the architectural and 
functional characteristics of the epithelia of Müllerian 
duct derivatives, such as Fallopian tube, endometrium 
or endocervix. Tubal metaplasia, the most common 
differentiation pathway in EICs, is characterized by the 
appearance of secretory and ciliated cells (arrowheads, 
Figure 9A and C) and expression of specific genes such 
as CA125 and oviductal glycoprotein [110]. Notably, 
differentiation of OSE cells in EICs through Müllerian 
pathways is associated with the presence of monocyte 
derived CD68 positive cells (MDC) that infiltrate the 
cyst wall and accumulate in the cyst lumen (arrows, 
Figure 9A and B) [111]. MDC are a source of active 
cytokines that could reach bioactive concentrations in 
the confined space of the EICs, thus affecting the 
differentiation and proliferative activity of epithelial 
cells (Figure 9C) contributing to the initial stages of 
OSE cell transformation. 
 
The levels of pro-inflammatory cytokines IL-1 alpha, 
IL-1 beta, IL-6 and TNF-alpha were higher in ovarian 
cancerous tissues than in normal specimens [112, 113]. 
The higher levels of these factors were detected mainly 
in epithelial cells of the tumor than in the surrounding 
stromal cells (Figure 9D and E). 
 
Altogether, there might be novel strategies for the 
targeting activity of MDC in "tissue control units" 
associated with cancer [109]. Figure 8N shows 
association of primitive CD14 MDC with growing 
malignant cells. CD14 is a lipopolysaccharide receptor 
[114], which inhibits activation of NK cells capable of 
recognizing and killing tumor cells [115]. It is possible 
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that temporary targeting of CD14 MDC, e.g. by CD14 
antibody [109], small interfering (si)RNA [116], or 
other approaches targeting tissue macrophages, may 
result in the regression of unstable (lack of autonomic 
innervation) "tissue control units" in malignant tissues, 
leading to activation of NK cells, and subsequent 





































These data indicate that malignant growth is associated 
with enhanced activity of mesenchymal cells, and tissue 
macrophages in particular. Novel approaches to cancer 
prevention and control may depend on a better 
understanding of the mechanisms by which tissue 
macrophages promote growth of tumor cells. In 
addition, studies of events accompanying regression of 
luteal tissue may be of importance for better 
understanding on how the regression of vascular 
components results in ultimate regression of 
epithelial/parenchymal and possibly malignant tissues 
[70]. 
IMMUNE ADAPTATION AND THE DETERMINA-
TION OF FUNCTIONAL TISSUE LIFESPAN 
 
During immune adaptation (through the end of the 
second trimester of intrauterine life in humans [99]), 
differentiating tissues are recognized by the developing 
lymphoid (immune) system as self [117-119]. However, 
depending on the time point at which a certain tissue 
arises during immune adaptation, cellular memory can 
determine how long MDC and T cell support will 
persist. In the ovary, these cells influence formation of 
new germ and granulosa cells and differentiation of 
primordial follicles [36, 57]. 
 
In normal adult individuals, the first organ affected by 
aging is the thymus [120], and the next are the ovaries 
[121, 122]. There is a correlation between the period at 
which an organ is present during early ontogeny and its 
functional longevity. For instance, the heart, which 
differentiates very early, can function in humans for 
over one hundred years. In contrast, the ovaries, which 
differentiate later, do not function for more than half 
that time (Figure 10A). We have proposed that the later 
the differentiation of certain tissues occurs during early 
ontogeny, the earlier its function expires during 
adulthood [31]. Ovarian development is influenced by 
mesenchymal-epithelial interactions which accompany 
the emergence of germ cells and follicular growth [4, 
57, 70]. Uncommitted MDC may first recognize and 
memorize the character of OSC, which differentiate 
from urogenital coelomic epithelium populated by 
primordial germ cells. In the fetal ovary, presumptive 
memory cells reside in the rete ovarii, and uncommitted 
MDC and T cells migrate through rete channels toward 
the ovarian surface and participate in the development 
of germ cells from the OSC [36]. Similar interaction of 
immune cells with OSC was described in the ovaries of 
adult women [57]. During adulthood, however, no rete 
is present in ovaries, so the memory cells may reside in 
the lymphoid tissues, the source of antigen-committed 
immunocytes [99]. The immune system shows a 
significant functional decrease between 35 and 40 years 
of age in women [123], and concomitantly ovarian 
follicular renewal wanes [35]. 
Figure 9. Macrophages, cytokines and ovarian cancer. Epithelial 
inclusion cysts (EIC), showing infiltration of the cyst wall (A) and 
lumen  (B)  by  CD68  positive  MDC  (arrows),  ciliated  cells
(arrowheads), and Ki67 positive  (arrow  in C) proliferating  cells.





Premature ovarian failure (POF) could be caused by 
delayed ovarian development during immune adaptation 
(SHORTER, Figure 10A), by earlier termination of 
immune adaptation, or by cytotoxic chemotherapy 
affecting both the existing pool of primordial follicles 
and the OSC committed bone marrow-derived cells (T 
cells in particular) required for the emergence of new 
secondary germ cells and hence for follicular renewal. 
Patients with POF have been found to have 
abnormalities in the function of circulating monocytes, 
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activated lymphocytes, and NK cells, and exhibit other 
immune abnormalities [124-126], suggesting a 





















































Thymus and reproduction 
 
The thymus plays an important role in the immune 
system, and it has been suggested that thymic peptides 
participate in determining the reproductive lifespan of 
females [127, 128]. The relationship between age-
associated thymic involution and diminution of ovarian 
function is evidenced by the alteration of ovarian 
function in neonatally thymectomized mice [129]. In 
congenitally athymic (nude) mice, follicular loss is first 
evident at 2 months of age, specifically due to a 
reduction in the numbers of primordial follicles. The 
first ovulation is delayed until two and a half months of 
age, compared to one and half months in normal mice. 
By four months, an overall reduction in all fractions of 
the follicle population occurs in nude mice, and 
ovulation ceases [130]. 
 
THE TISSUE CONTROL SYSTEM AND A "STOP-
EFFECT" OF MDC THEORY 
 
By the end of immune adaptation in early ontogeny, the 
MDC are proposed to encounter the most differentiated 
cells in a specific tissue, and prevent them from 
differentiating beyond the encoded state during 
adulthood by the so called "stop effect." The power of 
this "stop effect" may reside in the inability of 
monocyte-derived cells to stimulate differentiation of 
tissue cells beyond the encoded stage [3]. Retardation or 
acceleration of differentiation during immune 
adaptation may cause a permanent alteration of tissue 
function. If the ability of monocytes to preserve tissue 
cells in a functional state declines with age, a functional 
decline would ensue, leading to menopause and 
degenerative diseases. 
 
In large mammals including primates immune 
adaptation ceases during intrauterine life, while in 
laboratory rodents (rats and mice) immune adaptation 
continues for several postnatal days, ending about one 
week after birth [99]. Estrogens given to neonatal rats or 
mice inhibit ovarian development, and during adulthood 
females show persisting ovarian immaturity 
characterized by a retardation of follicular development 
[30] despite normal serum levels of gonadotropins [131, 
132]. This indicates that suppression of early ovarian 
development results in persisting ovarian immaturity, 
which resembles POF associated with the gonadotropin 
resistance of ovarian follicles. Injection of estrogens in 
neonatal mice (days 0-3) caused permanent anovulation, 
but mice injected later (days 3-6; closer to the end of 
immune adaptation) showed resumption of ovulatory 
cycles after initial anovulation [133]. Hence, persisting 
ovarian immaturity can result in a delay of normal 
ovarian function. Since the incidence of degenerative 
Figure  10.  Immune  adaptation  and  TCS  "stop  effect."  (A) 
Immune  adaptation  (IA)  and  tissue  longevity.  The  heart
differentiates  from  early  stages  of  ontogeny  (LONG  IA)  and
functions  throughout  life.  The  ovary  differentiates  later
(MODERATE  IA), and  its normal  function  is  limited by  follicular
renewal (until 35‐40 years of age). Aging primordial follicles (apf)
persist  until  exhausted  (physiologic  menopause).  SHORTER





degeneration,  except  during  pregnancy, which  is  accompanied
by  immune  suppression.  fpf,  fetal  primordial  follicles;  fr,
follicular  renewal;  POF,  premature  ovarian  failure;  CL,  corpus
luteum. Adapted from Ref. [31]. (B) Stages of cell differentiation
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diseases increases with age, one may expect the "stop-
effect" to shift with age (arrowheads, Figure 10B). This 
could explain why an immature ovary may switch to a 
functioning ovary. 
 
On the other hand, injection of androgens causes 
premature ovarian aging which persists during 
adulthood. However, androgen induced anovulation 
may be prevented by neonatal injection of a thymic cell 
suspension from immunocompetent prepubertal normal 
female donors, unless the animal donors did not 
complete immune adaptation [134, 135]. This suggests 
that certain thymic cells (thymocytes, or thymic MDC) 
of normal immunocompetent females carry information 
about appropriate differentiation of ovarian structures, 
and this information can be transferred to 
immunologically immature neonatal rats. Hence the 
state of tissue differentiation during immune adaptation 
determines tissue function in adult individuals. 
 
When a lower dose of androgens is injected during 
immune adaptation, the rats exhibit a so-called delayed 
anovulatory syndrome. Ovaries exhibit the onset of 
normal function after puberty (~40 days of age), but 
premature aging of the ovary occurs between 60-100 
days [136]. This delayed manifestation of ovarian 
dysfunction resembles human POF with secondary 
amenorrhea as well as some human degenerative 
diseases with an autoimmune character. The latter 
similarly occur after a shorter (juvenile diabetes 
mellitus) or longer (Alzheimer's disease) period of 
normal tissue function. 
 
A simplified view of the TCS theory of the regulation of 
tissue function via the "stop effect" (StE) is depicted in 
Figure 10B (see also [4, 17, 34]). In normal tissues, the 
mature cells are present during immune adaptation, and 
the tissue-specific cells are "parked" in the mature state 
during adulthood. Retardation of cell differentiation 
during adaptation results in persisting immaturity (POF 
with primary amenorrhea) and acceleration in premature 
aging (POF with secondary amenorrhea, degenerative 
diseases). If the tissue is absent during adaptation (e.g. 
corpus luteum), it will be handled immunologically as a 
"graft." 
 
IMMUNE PHYSIOLOGY AND REGENERATIVE 
MEDICINE 
 
Totipotency of ovarian stem cells in vitro 
 
Ovarian stem cells exhibit a totipotent character 
resembling embryonic stem cells, since they are able to 
differentiate in vitro into oocytes, parthenogenetic 
embryos, and neural/neuronal cell types, [94, 137, 138] 
and OSC cultures exhibit markers of embryonic stem 














































(black  arrow)  and  neuronal  (white  arrow)  cells.  White 
arrowhead indicates neuronal extension. (B) DAPI staining of (A). 
(C) The parthenote shows a blastocoele (white arrow) and inner 
cell  mass  (black  arrow).  (D)  DAPI  staining  of  (C).  Four  cell 
embryo.  (E  ‐ G)  and morula  (H  and  I).  J  and  K  panels  show  a 
blastocyst  consisting  of  blastocoele  (bc),  trophectoderm  (te), 
and inner cell mass (icm) releasing ESC (esc). Left insert in panel 





Advanced differentiation of oocytes in vitro produced 
oocytes of 200 μm diameter (Figure 11A) - note the 
wide ZP and compare with the small size of sur-
rounding cells. The oocyte was accompanied by satellite 
cells (black arrow) substituting for granulosa cells in 
providing additional resources (organelles) needed by 
the developing oocyte [141]. Also involved were 
neuronal type cells (white arrow) with an extension 
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(arrowhead) expanding over the oocyte. Panel B shows 
DAPI staining - note a large oocyte nucleus. Some 
oocytes differentiated into parthenogenetic embryos 
with extensively developed blastocoels (white arrows, 
panels C and D) and inner cell mass (black arrows). 
 
Deleted azoospermia like (DAZL) protein was strongly 
expressed in early parthenotes (arrowhead, Figure 11E), 
at the four cell stage (panels F and G). Resulting 
morulae (panels H and I; no immunohistochemistry) 
can develop into blastocysts that show production of 
DAZL+ embryonic stem cells (ESC) from the 
embryonic inner cell mass into the culture (arched 
arrow, panel J). The inner cell mass and the released 
ESC are mitotically active as compared to the other 
cells lacking DAZL expression and pronounced DAPI 
staining (left vs. right inset, panel K) [97, 137]. 
 
These observations indicate that OSC cultures could be 
a source of oocytes for the treatment of female ovarian 
infertility, and can also produce ESC for the purposes of 
autologous regenerative medicine. 
 
Epithelial to neural/neuronal transition is triggered 
by a mixture of sex steroids 
 
Within the field of regenerative medicine of 
neurodegenerative and traumatic neurologic diseases, 
there is considerable interest in cellular therapy, such as 
grafting of neural stem cells (NSC) into the CNS in 
order to induce neuronal renewal and repair of 
degenerative, traumatic or ischemic defects. Neural 
stem cells can be isolated from the neonatal or adult 
CNS and propagated in vitro in the presence of 
mitogenic growth factors prior to use [142, 143]. 
Alternative sources of NSC are ESC, umbilical cord 
blood, amniotic epithelial cells, bone marrow stem cells, 
and mobilized peripheral blood CD133+ cells [144-
147]. After several passages, these cells can be 
transdifferentiated into NSC either by fibroblast growth 
factor-1, 12-otetradecanoylphorbol-13-acetate (protein 
kinase C activator), isobutyl-methylxanthine (a non-
specific inhibitor of phospho-diesterases), and forskolin 
(protein kinase A activator), or by all-trans-retinoic acid 
and 2-mercaptoethanol [148]. These substances are not 
suitable for treatment in vivo, however. Previous work 
from our laboratory demonstrated that occasionally, 
neuronal cells spontaneously appear in cultures of 
human ovarian epithelial stem cells [94]. 
 
An alternative to the use of organ- tissue specific stem 
cells for functional grafting to particular sites (topical 
therapy) could be a "systemic regenerative treatment" 
with utilization of common drugs with a low molecular  
weight. Sex steroids may have the potential to stimulate 
the proliferation and differentiation of existing NSC. 
They easily pass the blood-brain barrier and can bind to 
abundant sex steroid receptors in the brain areas 
important for the regulation of emotions, cognition, and 
behavior [149]. However it still remains to be 
determined whether utilization of individual sex steroids 
alone might be efficient in prevention or treatment of 
neurodegenerative diseases and traumatic neurologic 
injuries. To address this question, we studied the effects 
of sex steroids on the transdifferentiation of totipotent 
human ovarian epithelial stem cells and porcine 
granulosa cells into NSC and neuronal cells [138]. 
 
Human ovarian epithelial stem cells differentiated into 
large epithelial cells lacking expression of stage specific 
embryonic antigen (SSEA) -1 (Figure 12A) and neural 
cell adhesion moleculae (NCAM; not shown). A few 
epithelial cells in untreated cultures showed moderate 
staining for Thy-1 (panel B) and similar expression of 
SSEA-4 (not shown). Addition of individual 
gonadotropins, EGF, or sex steroids alone showed no 
change in either cell morphology or immune-
histochemical staining. No changes were observed in 
control cultures including those with the sex steroid 
vehicle.  
 
On the other hand, utilization of testosterone (TS) 
mixed with progesterone (PG) one day after estradiol 
(E2) pretreatment produced a marked effect after one 
hour. There was transdifferentiation of epithelial cell 
clusters into small cells, a portion of which strongly 
expressed SSEA-1 glycoconjugate of NSC and 
precursor cells [150] and others were less densely 
SSEA-1 positive (black vs. solid grey arrowheads, 
panels C and D). An asymmetric division resulting in 
SSEA-1+ and SSEA-1- daughter cells is shown in panel 
E; note stained early extensions (arrow) associated with 
the SSEA-1+ cell. Many of the nascent small cells 
strongly expressed Thy-1, a GPI-anchored protein 
abundantly expressed by neurons [151]. Particularly 
strong expression was apparent in cells detaching from 
the moderately stained cluster of cells (black vs. solid 
grey arrowheads, panel F). The detached cells, however, 
still showed connections (arrows) with the cell cluster. 
More distant cells exhibited development of Thy-1+ 
extending processes (left black arrowhead), suggesting 
early stages of neuronal differentiation. Some larger 
cells with developed extensions strongly expressed 
NCAM (black arrowhead, panel G), which is charac-
teristic of later stages of neuronal differentiation [150]. 
Antibody to NCAM is used for the isolation of human 
ESC-derived neurons [150]. Less developed (smaller)  
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cells in the cluster showed moderate NCAM expression 





















































Three hours after the TS+PG mixture following E2 
pretreatment (panels H-O), the cells showed an 
advanced neuronal morphology with mutually 
connected extending processes, suggesting what we 
term "brain in vitro" features. Stage-specific embryonic 
antigen-1 expression was limited to neuronal cell 
bodies, and their extending processes were unstained 
(black vs. white arrowheads, panel H). The neuronal 
cells strongly expressed Thy-1 glycoprotein in both the 
cell bodies and extending processes (black arrowheads, 
panel I), and the same applied for NCAM expression 
(panel J). Stage-specific embryonic antigen-4 is 
commonly used as a cell surface marker to identify 
pluripotent human ESC and expressing cells enriched in 
the neural stem/progenitor cell fraction [152]. It was 
strongly expressed in neuronal cell bodies but virtually 
absent in extending processes (black vs. white 
arrowhead, panel K). Control immunohistochemistry 
produced no staining of neuronal (white arrowhead, 
panel L) or other cell types. In phase contrast 
observations, the neuronal phenotype cells were shown 
to interact with remaining epithelial cells (panel M). 
Large numbers of putative NSC detached from the 
bottom of the flasks and were found floating in the 
center of the wells (panel N). These cells showed 
bubble type anchoring extensions (arrowheads, panel 
O), which apparently serve to attach seeded non-
neuronal cells [138]. Since such putative NSC did not 
attach again, they may be ready for homing where 
needed. 
 
In summary, OSC cultures could produce oocytes 
suitable for in vitro fertilization [153], and the treatment 
can be complemented by implantation of fertilized 
oocytes in the uterus regardless of the type of ovarian 
failure. However, regenerative medicine for 
neurodegenerative and traumatic neurologic diseases 
depends on local TCS interactions in the given tissue in 
the particular individual. For instance local or systemic 
implantation of NSC in Alzheimer’s disease does not 
preclude that such cells will differentiate into mature 
neurons, if the brain lacks neurosteroids and MDC-
derived microglia, supposed to be required for such a 
process. Moreover, even when such substances and 
cells are available, the differentiating neurons may not 
be preserved in a functional state and may continue to 
degenerate due to the lack of a proper “stop-effect” (see 
Figure 10B). Proper conditions can be, however, 
expected in the traumatic neurologic diseases, where 
regenerative medicine or systemic regenerative 
treatment may result in a more favorable outcome. 
Recently, NSC derived from human ESC have been 
shown to engraft functionally in an experimental mouse 
model with an improvement of sensimotor function of 
the stroke-disabled forelimb [154]. 




(H‐O).  Lack  of  SSEA‐1  expression  (A)  and  moderate  Thy‐1 
expression  by  some  epithelial  cells  (B).  SSEA‐1  is  strongly






processes  (H,  black  vs.  white  arrowheads),  Thy‐1  and  NCAM
expression  in  both  (I  and  J,  black  arrowheads),  and  SSEA‐4 
expression slightly exceeding that of SSEA‐1 (K vs. H). No staining 
was  observed  in  the  immunohistochemistry  control  (L).  Panels 
M‐O  show  phase  contrast  microscopy  with  neuronal  and
epithelial  cells  (M),  floating  numerous  putative  NSC  (N),  and 
putative NSC  exhibiting  bubble  type  anchors  (arrowheads, O). 
Numbers  above  bars  indicate  microns.  For  details  see  text.
Adapted from Ref. [138], © Landes Bioscience. 
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CONCLUDING REMARKS 
 
Altogether, available data indicate that in addition to its 
classically defined role in host defense via immune 
surveillance, the immune system is integral to the 
differentiation and maintenance of normal tissues via 
immune physiology. Further study of the TCS, 
including its involvement in CL development and 
regression, may also help us understand mechanisms of 
malignancy and metastasis, and their treatment and 
prevention. Better understanding of TCS involvement in 
the preservation of functional tissue longevity via the 
“stop effect” of MDC could assist in the meaningful 
utilization of regenerative medicine and systemic 
regenerative treatment. 
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